Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (15132) 15132
Newspaper Article (354) 354
Book Chapter (230) 230
Magazine Article (51) 51
Newsletter (38) 38
Dissertation (11) 11
Reference (7) 7
Book / eBook (6) 6
Conference Proceeding (6) 6
Book Review (3) 3
Web Resource (3) 3
Transcript (2) 2
Publication (1) 1
Streaming Video (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (10886) 10886
life sciences & biomedicine (10194) 10194
dopamine (7824) 7824
humans (7414) 7414
animals (7402) 7402
male (6547) 6547
neurosciences & neurology (5704) 5704
neurosciences (5657) 5657
pharmacology & pharmacy (4284) 4284
biological and medical sciences (4064) 4064
psychiatry (3792) 3792
medical sciences (3727) 3727
rats (3493) 3493
female (3341) 3341
dopamine - metabolism (2581) 2581
pharmacology. drug treatments (2330) 2330
adult (2004) 2004
schizophrenia (1942) 1942
mice (1877) 1877
neurology (1818) 1818
parkinson's disease (1785) 1785
neuropharmacology (1724) 1724
dose-response relationship, drug (1720) 1720
psychology. psychoanalysis. psychiatry (1715) 1715
rats, sprague-dawley (1687) 1687
clinical neurology (1676) 1676
rodents (1674) 1674
psychopharmacology (1648) 1648
middle aged (1479) 1479
dopamine receptors (1466) 1466
serotonin (1306) 1306
nervous system (1217) 1217
biomedicine (1212) 1212
disease models, animal (1208) 1208
brain (1168) 1168
research (1155) 1155
pharmacology/toxicology (1136) 1136
antipsychotic agents - therapeutic use (1132) 1132
dopamine antagonists - therapeutic use (1096) 1096
neurons (1057) 1057
analysis (1054) 1054
dopamine antagonists - pharmacology (1030) 1030
mental disorders (1030) 1030
schizophrenia - drug therapy (1005) 1005
cocaine (980) 980
drug therapy (978) 978
pharmacology (952) 952
aged (905) 905
parkinson disease - drug therapy (904) 904
motor activity - drug effects (898) 898
brain - metabolism (895) 895
dopamine agonists - therapeutic use (889) 889
treatment outcome (876) 876
phenols (872) 872
receptors, dopamine d2 - metabolism (861) 861
behavior, animal - drug effects (860) 860
movement disorders (851) 851
brain - drug effects (850) 850
medicine (843) 843
health aspects (838) 838
parkinsons disease (822) 822
rats, wistar (815) 815
time factors (814) 814
receptors (796) 796
neuroscience (790) 790
psychopathology. psychiatry (777) 777
dopamine agonists - pharmacology (767) 767
physiological aspects (756) 756
proteins (756) 756
psychotropic drugs (756) 756
care and treatment (752) 752
biochemistry & molecular biology (747) 747
research article (741) 741
studies (739) 739
neurodegenerative diseases (738) 738
corpus striatum - metabolism (728) 728
mice, inbred c57bl (725) 725
antipsychotic agents - pharmacology (707) 707
toxicology (700) 700
dopamine d2 receptors (685) 685
neurotransmitters (683) 683
science & technology - other topics (682) 682
adult and adolescent clinical studies (670) 670
multidisciplinary sciences (670) 670
dopamine - physiology (666) 666
fundamental and applied biological sciences. psychology (664) 664
reinforcement (662) 662
neostriatum (658) 658
corpus striatum - drug effects (657) 657
drugs (657) 657
reward (656) 656
glutamate (641) 641
nucleus accumbens (627) 627
drug abuse (618) 618
abridged index medicus (603) 603
behavior (603) 603
drug dosages (601) 601
psycholeptics: tranquillizer, neuroleptic (600) 600
double-blind method (591) 591
medicine & public health (577) 577
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15508) 15508
German (96) 96
French (92) 92
Japanese (68) 68
Russian (47) 47
Spanish (41) 41
Portuguese (24) 24
Polish (21) 21
Hungarian (17) 17
Italian (12) 12
Dutch (10) 10
Chinese (9) 9
Danish (7) 7
Finnish (5) 5
Turkish (5) 5
Romanian (4) 4
Czech (3) 3
Ukrainian (3) 3
Bulgarian (2) 2
Hebrew (2) 2
Lithuanian (2) 2
Croatian (1) 1
Korean (1) 1
Norwegian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Dopamine D3 receptor antagonists as therapeutic agents
by Joyce, Jeffrey N and Millan, Mark J
Drug discovery today, ISSN 1359-6446, 07/2005, Volume 10, Issue 13, pp. 917 - 925
Schizophrenia | positive symptoms | limbic system | extrapyramidal | cognition | cocaine | Pharmaceutical technology. Pharmaceutical industry | Biological and medical sciences | Medical sciences | General pharmacology | Pharmacology. Drug treatments | Humans | Dopamine Antagonists - therapeutic use | Technology, Pharmaceutical - methods | Tetrahydroisoquinolines - therapeutic use | Substance-Related Disorders - physiopathology | Technology, Pharmaceutical - trends | Animals | Substance-Related Disorders - prevention & control | Receptors, Dopamine D3 - physiology | Molecular Structure | Receptors, Dopamine D3 - antagonists & inhibitors | Dopamine Antagonists - chemistry | Nitriles - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Intravenous buspirone for the prevention of postoperative nausea and vomiting
by Kranke, Peter and Röhm, Kerstin D and Diemunsch, Pierre and Gan, Tong J and Apfel, Christian C and Eberhart, Leopold and Minkowitz, Harold S and Wallenborn, Jan and Chassard, Dominique and Lebuffe, Gilles and Fox, Gabriel M and Tramèr, Martin R
European journal of clinical pharmacology, ISSN 0031-6970, 11/2012, Volume 68, Issue 11, pp. 1465 - 1472
Biomedicine | Buspirone | Pharmacology/Toxicology | Randomised clinical trial | Antiemetic | Postoperative nausea and vomiting | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Anti-Anxiety Agents - administration & dosage | Injections, Intravenous | Buspirone - blood | Dopamine Antagonists - pharmacokinetics | Humans | Middle Aged | Receptors, Dopamine D3 - metabolism | Antiemetics - administration & dosage | Male | Buspirone - pharmacokinetics | Receptors, Dopamine D2 - metabolism | Dopamine Antagonists - administration & dosage | Incidence | Dose-Response Relationship, Drug | Young Adult | Anti-Anxiety Agents - pharmacokinetics | Buspirone - administration & dosage | Antiemetics - pharmacokinetics | Antiemetics - therapeutic use | Aged, 80 and over | Adult | Anti-Anxiety Agents - adverse effects | Antiemetics - adverse effects | Female | Anti-Anxiety Agents - therapeutic use | Buspirone - adverse effects | Receptors, Dopamine D3 - antagonists & inhibitors | Buspirone - therapeutic use | Receptor, Serotonin, 5-HT1A - metabolism | Postoperative Nausea and Vomiting - epidemiology | Double-Blind Method | Dopamine Antagonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - therapeutic use | Serotonin 5-HT1 Receptor Agonists - adverse effects | Postoperative Nausea and Vomiting - prevention & control | Receptor, Serotonin, 5-HT1A - chemistry | Buspirone - analogs & derivatives | Dopamine Antagonists - adverse effects | Serotonin 5-HT1 Receptor Agonists - administration & dosage | Aged | Dopamine D2 Receptor Antagonists | Postoperative Nausea and Vomiting - blood | Prevention | Complications and side effects | Buspirone hydrochloride | Adults | Nausea | Analysis | Postoperative period | Vomiting | Clinical trials | Pharmacology | Drug therapy | Clinical outcomes | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Melanin concentrating hormone receptor 1 (MCHR1) antagonists—Still a viable approach for obesity treatment?
by Högberg, Thomas and Frimurer, Thomas M and Sasmal, Pradip K
Bioorganic & medicinal chemistry letters, ISSN 0960-894X, 10/2012, Volume 22, Issue 19, pp. 6039 - 6047
GPCR structures | Obesity | Melanin concentrating hormone (MCH) | MCHR1 antagonists | hERG | Chemometric analysis | Physical Sciences | Chemistry | Chemistry, Organic | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Chemistry, Medicinal | Science & Technology | Biological and medical sciences | Pharmacology. Drug treatments | Medical sciences | Naphthalenes - chemistry | Piperidines - chemistry | Obesity - drug therapy | Humans | Models, Molecular | Crystallography, X-Ray | Structure-Activity Relationship | Pyrimidines - pharmacology | Biphenyl Compounds - therapeutic use | Anti-Obesity Agents - therapeutic use | Pyrimidines - chemistry | Naphthalenes - pharmacology | Ether-A-Go-Go Potassium Channels - antagonists & inhibitors | Anti-Obesity Agents - chemistry | Biphenyl Compounds - pharmacology | Piperidines - pharmacology | Piperidines - therapeutic use | Pyrimidines - therapeutic use | Drug Design | Receptors, Somatostatin - antagonists & inhibitors | Molecular Structure | Biphenyl Compounds - chemistry | Anti-Obesity Agents - pharmacology | Naphthalenes - therapeutic use | Hormones | Drug therapy | Free radicals (Chemistry) | Analysis | Index Medicus | Indexing in process
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Spinal segmental and supraspinal mechanisms underlying the pain-relieving effects of spinal cord stimulation: An experimental study in a rat model of neuropathy
by Barchini, J and Tchachaghian, S and Shamaa, F and Jabbur, S.J and Meyerson, B.A and Song, Z and Linderoth, B and Saadé, N.E
Neuroscience, ISSN 0306-4522, 2012, Volume 215, pp. 196 - 208
Neurology | GABA | 5HT | neuropathic pain | spinal cord stimulation | noradrenaline | dopamine | Dopamine | Noradrenaline | Spinal cord stimulation | Neuropathic pain | Neurosciences | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Fundamental and applied biological sciences. Psychology | Vertebrates: nervous system and sense organs | Biological and medical sciences | Pain Threshold - physiology | Baclofen - analogs & derivatives | Phentolamine - therapeutic use | Propranolol - therapeutic use | Electrodes - adverse effects | Adrenergic alpha-Antagonists - therapeutic use | GABA Antagonists - therapeutic use | Bicuculline - therapeutic use | Adrenergic beta-Antagonists - pharmacology | Time Factors | Pain Threshold - drug effects | Female | Neuralgia - physiopathology | Baclofen - therapeutic use | Disease Models, Animal | Sulpiride - therapeutic use | Ketanserin - therapeutic use | Rats | Serotonin Antagonists - therapeutic use | Methysergide - therapeutic use | Rats, Sprague-Dawley | Hyperalgesia - physiopathology | Pain Measurement - methods | Animals | Hyperalgesia - therapy | Analysis of Variance | Dopamine Antagonists - pharmacology | Spinal Cord - physiology | Neuralgia - therapy | Transcutaneous Electric Nerve Stimulation - methods | Physiological aspects | Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Tardive dyskinesia (syndrome): Current concept and modern approaches to its management
by Lerner, Paul P and Miodownik, Chanoch and Lerner, Vladimir
Psychiatry and clinical neurosciences, ISSN 1323-1316, 06/2015, Volume 69, Issue 6, pp. 321 - 334
first‐generation agents | schizophrenia | management | second‐generation agents | tardive dyskinesia | second-generation agents | first-generation agents | Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Stilbenes - therapeutic use | Antipsychotic Agents - adverse effects | Humans | Propranolol - therapeutic use | Leucine - therapeutic use | Dopamine Agents - therapeutic use | Amantadine - therapeutic use | Piracetam - therapeutic use | Pyridoxine - therapeutic use | Clonazepam - therapeutic use | Drugs, Chinese Herbal - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Adrenergic Uptake Inhibitors - therapeutic use | Anticonvulsants - therapeutic use | Nootropic Agents - therapeutic use | Isoleucine - therapeutic use | Vitamins - therapeutic use | Ginkgo biloba | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Movement Disorders - etiology | Piracetam - analogs & derivatives | Melatonin - therapeutic use | Fatty Acids, Omega-3 - therapeutic use | Valine - therapeutic use | Isoxazoles - therapeutic use | Plant Extracts - therapeutic use | Movement Disorders - drug therapy | Tetrabenazine - therapeutic use | Schizophrenia | Movement disorders | Tardive dyskinesia | Medical research | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Alternative pharmacological strategies for adult ADHD treatment: a systematic review
by Buoli, Massimiliano and Serati, Marta and Cahn, Wiepke
Expert review of neurotherapeutics, ISSN 1473-7175, 02/2016, Volume 16, Issue 2, pp. 131 - 144
Antidepressants | Attention Deficit Hyperactivity Disorder (ADHD) | Amphetamines | Efficacy | Lithium | Adults | Pharmacological Treatment | Metadoxine | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Humans | Paroxetine - therapeutic use | Venlafaxine Hydrochloride - therapeutic use | Dopamine Agents - therapeutic use | Droxidopa - therapeutic use | Pyrrolidonecarboxylic Acid - therapeutic use | Adrenergic alpha-Agonists - therapeutic use | Histamine Agents - therapeutic use | Central Nervous System Stimulants - therapeutic use | Desipramine - therapeutic use | Bridged Bicyclo Compounds, Heterocyclic - therapeutic use | Pyridoxine - therapeutic use | Adult | Lobeline - therapeutic use | Benzhydryl Compounds - therapeutic use | Nomifensine - therapeutic use | Morpholines - therapeutic use | Bupropion - therapeutic use | Pyridines - therapeutic use | Wakefulness-Promoting Agents - therapeutic use | Duloxetine Hydrochloride - therapeutic use | Guanfacine - therapeutic use | Nicotinic Agonists - therapeutic use | Attention Deficit Disorder with Hyperactivity - drug therapy | Antidepressive Agents - therapeutic use | Mecamylamine - therapeutic use | Amphetamines - therapeutic use | Lithium Compounds - therapeutic use | Lisdexamfetamine Dimesylate - therapeutic use | Nicotinic Antagonists - therapeutic use | Quinazolinones - therapeutic use | Memantine - therapeutic use | Drug Combinations | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Novel pharmacological targets for the treatment of Parkinson's disease
by Ferger, Borris and Novère, Nicolas Le and Davidai, Giora and Brotchie, Jonathan and Bezard, Erwan and Obeso, José A and Spampinato, Umberto and Collingridge, Graham L and Jenner, Peter and Schwarzschild, Michael A and Hirsch, Etienne and Hengerer, Bastian and Calon, Frédéric and Schapira, Anthony H. V
Nature reviews. Drug discovery, ISSN 1474-1776, 10/2006, Volume 5, Issue 10, pp. 845 - 854
Pharmacology & Pharmacy | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Monoamine Oxidase Inhibitors - therapeutic use | Excitatory Amino Acid Antagonists - therapeutic use | Antiparkinson Agents - pharmacology | Cholinergic Agents - therapeutic use | Humans | Dopamine Agonists - therapeutic use | Serotonin Antagonists - therapeutic use | Clinical Trials as Topic | Parkinson Disease - drug therapy | Adenosine A2 Receptor Antagonists | Antiparkinson Agents - therapeutic use | Serotonin Receptor Agonists - therapeutic use | Narcotic Antagonists - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights